Low-Density Lipoprotein Density and Atherosclerosis: Unraveling the Connection

JAMA: The Journal of the American Medical Association

Volumn 272, Issue 4, 1994, Pages 305-308

  Slyper, Arnold H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIET; DISEASE ASSOCIATION; EXERCISE; FAMILIAL HYPERLIPEMIA; HUMAN; LIPID ANALYSIS; LIPID PEROXIDATION; LIPID STORAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

EID: 0028239583     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03520040067042     Document Type: Article

References (36)

1. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb. 1992;12:1496-1502.
2. Austin MA. Low-density lipoprotein subclass phenotypes and familial combined hyperlipidemia. Diabetes Metab Rev. 1991;7:173-177.
3. Hunt SC, Wu LL, Hopkins PN, et al. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia: study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 1989;9:335-344.
4. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
5. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: results from the Framingham Offspring Study. Arteriosclerosis. 1987;7:483-490.
6. Campos H, Blijlevens E, McNamara JR, et al. LDL particle size distribution: results from the Framingham Offspring Study. Arterioscler Thromb. 1992;12:1410-1419.
7. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
8. Austin MA, King M-C, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495-506.
9. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 1988;43:838-846.
10. Tornvall P, Karpe F, Carlson LA, Hamsten A. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis. 1991;90:67-80.
11. Crouse JR, Parks JS, Schey HM, Kahl FR. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 1985;26:566-574.
12. Schaefer EJ, McNamara JR, Genest J, et al. LDL particle size, lipoproteins, and apolipoproteins in premature coronary artery disease (CAD): confounding effects of beta blockers. Circulation. 1987; 76(suppl IV):531.
13. Campos H, Genest JJ, Blijlevens E, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
14. Barakat HA, Carpenter JW, McLondon VD, et al. Influence of obesity, impaired glucose tolerance, and MDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes. 1990;39:1527-1533.
15. Reaven UM, Ida Chen Y-D, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest. 1993; 92:141-146.
16. Teng B, Thompson OR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO. Composition and distribution of low density lipoprotein fractions and hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1983;80:6662-6666.
17. Deckelbaum RI, Uranot E, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis. 1984;4:225-231.
18. Auwerx JH, Marzetta CA, Hokanson JE, Brunzell JD. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis. 1989;9:319-325.
19. Krauss RM. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. Am Heart J. 1987;113:578-582.
20. Austin MA, King M-C, Vranizan KM, Newman B, Krauss M. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 1988;43:838-846.
21. Lamon-Fava S, Jimenez D, Christian JC, et al. The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis. 1991;91:97-106.
22. Williams PT, Krauss RM, Wood PD, Lindgren FT, Uiotas C, Vranizan KM. Lipoprotein subfractions of runners and sedentary men. Metabolism. 1986;35:45-52.
23. Lamon-Fava S, Fisher EC, Nelson ME, et al. Effect of exercise and menstrual cycle status on plasma lipids, low density lipoprotein particle size, and apolipoproteins. J Clin Endocrinol Metab. 1989; 68:17-21.
24. Terry RR, Wood PD, Haskell WL, Stefanick ML, Krauss RM. Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. J Clin Endocrinol Metab. 1989;68:191-199.
25. Campos H, Bailey SM, Uussack LS, Siles X, Ordovas JM, Schaefer EJ. Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arterioscler Thromb. 1991;11:1077-1088.
26. Williams PT, Krauss RM, Kindel-Joyce S, Dreon DM, Vranizan KM, Wood PD. Relationship of dietary fat, protein, cholesterol, and fiber intake to atherogenic lipoproteins in men. Am J Clin Nutr. 1986;44:788-797.
27. Knight BL, Thompson UR, Soutar AK. Binding and degradation of heavy and light subfractions of low density lipoprotein by cultured fibroblasts and macrophages. Atherosclerosis. 1986;59:301-306.
28. Thompson GR, Teng B, Sniderman AD. Turnover of apo B in low density lipoprotein sub-fractions. In: Parnham JJ, ed. Cologne Atherosclerosis Conference II: Lipids, Agents and Actions. Basel, Switzerland: Birkhauser; 1984:121-125.
29. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
30. Cominacini L, Garbin U, Pastorino AM, et al. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis. 1993;99:63-70.
31. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992;93:189-199.
32. de Uraaf J, Hak-Lommers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in health subjects. Arterioscler Thromb. 1991;11:298-306.
33. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473-485.
34. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta. 1983;737:197-222.
35. Slyper AH. A fresh look at the atherogenic hypothesis. Lancet. 1992;340:289-291.
36. Ida Chen Y-D, Reaven GM. Intestinally derived lipoproteins: metabolism and clinical significance. Diabetes Metab Rev. 1991;7:191-208.